Structured products disclosure under scrutiny
The Australian Securities and Investments Commission (ASIC) has updated its disclosure guidance for capital protected products and retail structured or derivative products marketed to retail investors.
The report is a result of a program started by ASIC in January 2009 and has involved the review of 64 Product Disclosure Statements for adequacy of disclosure.
In its review, ASIC focused on capital protected products as it believed investors might be attracted to these investments due to a perception of capital safety without fully comprehending the inherent risks. It also examined structured and derivative products marketed to retail investors where associated risks and costs might not be anticipated or understood.
Following the review, ASIC has made recommendations that issuers of these products should make more effective disclosure to prospective investors by clearly explaining counterparty risk and by including supporting financial information to ensure retail investors can assess the issuer’s financial ability to meet its counterparty obligations.
Further recommendations saw issuers of capital protected products urged to ensure disclosure is sufficient so that investors can assess the likelihood of early termination or any other significant limitations of these products. It also stressed issuers provide better disclosure costs that may apply should an investor seek to terminate or redeem a product before its maturity date.
Recommended for you
Over half of wealth management clients in Asia-Pacific say they are looking for more advice in investment and financial planning services, according to EY, and may switch or add new providers to achieve this.
As artificial intelligence continues to reshape how the advice industry operates, Adviser Ratings unpacks which areas advisers are using the technology to improve the client experience.
Insignia Financial has appointed the former APAC head of a global asset manager to its board.
Financial advisers have been warned against advising clients to withdraw superannuation for medical or dental treatments as a new report highlights the long-term effect on balances at retirement.